1-5 of 5
N. Lynn Henry
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

Vered Stearns, Opeyemi A. Jegede, Victor T.-S. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand, Atif Shafqat, Nisha L. Jacobs, William Luginbuhl, Paul Gilman, Al B. Benson, III, Judie R. Goodman, Gary L. Buchschacher, Jr, N. Lynn Henry, Charles L. Loprinzi, Patrick J. Flynn, Edith P. Mitchell, Michael J. Fisch, Joseph A. Sparano, Lynne I. Wagner
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (13): 2709–2718.
https://doi.org/10.1158/1078-0432.CCR-23-2137
Published: 01 July 2024
View articletitled, A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
Open the PDF for A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11 in another window
Includes: Supplementary data
Journal Articles

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Daniel L. Hertz, Kelley M. Kidwell, Kiran Vangipuram, Feng Li, Manjunath P. Pai, Monika Burness, Jennifer J. Griggs, Anne F. Schott, Catherine Van Poznak, Daniel F. Hayes, Ellen M. Lavoie Smith, N. Lynn Henry
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3602–3610.
https://doi.org/10.1158/1078-0432.CCR-18-0656
Published: 31 July 2018
View articletitled, Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy
Open the PDF for Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy in another window
Includes: Supplementary data
Journal Articles

Palbociclib for the Treatment of Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer

Aki Morikawa, N. Lynn Henry
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16): 3591–3596.
https://doi.org/10.1158/1078-0432.CCR-15-0390
Published: 13 August 2015
View articletitled, Palbociclib for the Treatment of Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer
Open the PDF for Palbociclib for the Treatment of Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer

Costanza Paoletti, Maria C. Muñiz, Dafydd G. Thomas, Kent A. Griffith, Kelley M. Kidwell, Nahomi Tokudome, Martha E. Brown, Kimberly Aung, M. Craig Miller, Dorothy L. Blossom, Anne F. Schott, N. Lynn Henry, James M. Rae, Mark C. Connelly, David A. Chianese, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2487–2498.
https://doi.org/10.1158/1078-0432.CCR-14-1913
Published: 31 May 2015
View articletitled, Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
Open the PDF for Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Cytoplasmic Estrogen Receptor in Breast Cancer

Allison W. Welsh, Donald R. Lannin, Gregory S. Young, Mark E. Sherman, Jonine D. Figueroa, N. Lynn Henry, Lisa Ryden, Chungyeul Kim, Richard R. Love, Rachel Schiff, David L. Rimm
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (1): 118–126.
https://doi.org/10.1158/1078-0432.CCR-11-1236
Published: 02 January 2012
View articletitled, Cytoplasmic Estrogen Receptor in Breast Cancer
Open the PDF for Cytoplasmic Estrogen Receptor in Breast Cancer in another window
Includes: Supplementary data